Clinical trial
Curcuminoids for the Treatment of Chronic Psoriasis Vulgaris
NCT00235625 · University of Pennsylvania, Other · Completed
Key facts
| NCT number | NCT00235625 |
|---|---|
| Title | Curcuminoids for the Treatment of Chronic Psoriasis Vulgaris |
| Official title | A Phase II Open Label Study of the Safety and Efficacy of Curcuminoids C3 Complex® in Patients With Chronic Psoriasis Vulgaris. |
| Lead sponsor | University of Pennsylvania, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Psoriasis |
| Intervention type | Drug |
| Interventions | Curcuminoids C3 Complex® |
| Enrollment | 12 |
| Start date | Oct 1, 2005 |
| Completion | Nov 1, 2007 |
| First posted | Oct 10, 2005 |
| Last update posted | Dec 17, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: